The Role of Surgery in the Management of Intestinal Diffuse Large B-Cell Lymphoma (DLBCL): A Propensity Score-Matched Analysis.
3/5 보강
TL;DR
Combined surgical treatment manifested a better survival outcome than conservative treatment for patients with intestinal DLBCL and indicated that serum lactate dehydrogenase level, bone marrow involvement, and surgical intervention are independent prognostic factors for survival.
PICO 자동 추출 (휴리스틱, conf 3/4)
유사 논문P · Population 대상 환자/모집단
118 patients diagnosed with intestinal DLBCL who received systemic therapy from 2011 to 2020 were retrospectively enrolled.
I · Intervention 중재 / 시술
systemic therapy from 2011 to 2020 were retrospectively enrolled
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSION] Combined surgical treatment manifested a better survival outcome than conservative treatment for patients with intestinal DLBCL. Serum lactate dehydrogenase level, bone marrow involvement, and surgical intervention are independent prognostic factors for survival.
OpenAlex 토픽 ·
Lymphoma Diagnosis and Treatment
Chronic Lymphocytic Leukemia Research
Esophageal Cancer Research and Treatment
Combined surgical treatment manifested a better survival outcome than conservative treatment for patients with intestinal DLBCL and indicated that serum lactate dehydrogenase level, bone marrow involv
- p-value p<0.001
- p-value p=0.021
APA
Kefan Dai, Yue LI, et al. (2026). The Role of Surgery in the Management of Intestinal Diffuse Large B-Cell Lymphoma (DLBCL): A Propensity Score-Matched Analysis.. Annals of surgical oncology, 33(5), 4721-4730. https://doi.org/10.1245/s10434-026-19211-1
MLA
Kefan Dai, et al.. "The Role of Surgery in the Management of Intestinal Diffuse Large B-Cell Lymphoma (DLBCL): A Propensity Score-Matched Analysis.." Annals of surgical oncology, vol. 33, no. 5, 2026, pp. 4721-4730.
PMID
41721164 ↗
Abstract 한글 요약
[BACKGROUND] The role of surgery in the management of intestinal diffuse large B-cell lymphoma (DLBCL) remains controversial. The study aimed to investigate the efficacy of surgery and explore the prognostic factors for patients with intestinal DLBCL.
[METHOD] A total of 118 patients diagnosed with intestinal DLBCL who received systemic therapy from 2011 to 2020 were retrospectively enrolled. Patients were divided into the conservative treatment group and the surgical treatment group based on whether they underwent surgical intervention prior to systemic therapy. Propensity score matching (PSM) analysis was utilized to control the confounding factors. Survival and Cox regression analyses were performed to evaluate the long-term outcome and prognostic risk factors.
[RESULTS] Patients in the surgical treatment group had significantly higher progression-free survival (PFS) rates than patients who received conservative treatment (3-year PFS: 84.6% vs. 35.9%, p<0.001; 5-year PFS: 53.8% vs. 28.2%, p=0.021). The overall survival (OS) rates of the surgery group were also significantly higher than those of the conservative treatment group (3-year OS: 87.2% vs. 43.6%, p<0.001; 5-year OS: 56.4% vs. 30.8%, p=0.022). Surgical treatment was associated with a higher complete response rate and a lower disease progression/relapse rate (complete response rate: 87.2% vs. 53.8%, p=0.001; progression/relapse rate: 10.3% vs. 28.2%, p=0.044). Multivariate Cox regression analysis indicated that serum lactate dehydrogenase level and surgical intervention were independent prognostic factors for both PFS and OS, whereas bone marrow involvement was an independent prognostic factor for PFS.
[CONCLUSION] Combined surgical treatment manifested a better survival outcome than conservative treatment for patients with intestinal DLBCL. Serum lactate dehydrogenase level, bone marrow involvement, and surgical intervention are independent prognostic factors for survival.
[METHOD] A total of 118 patients diagnosed with intestinal DLBCL who received systemic therapy from 2011 to 2020 were retrospectively enrolled. Patients were divided into the conservative treatment group and the surgical treatment group based on whether they underwent surgical intervention prior to systemic therapy. Propensity score matching (PSM) analysis was utilized to control the confounding factors. Survival and Cox regression analyses were performed to evaluate the long-term outcome and prognostic risk factors.
[RESULTS] Patients in the surgical treatment group had significantly higher progression-free survival (PFS) rates than patients who received conservative treatment (3-year PFS: 84.6% vs. 35.9%, p<0.001; 5-year PFS: 53.8% vs. 28.2%, p=0.021). The overall survival (OS) rates of the surgery group were also significantly higher than those of the conservative treatment group (3-year OS: 87.2% vs. 43.6%, p<0.001; 5-year OS: 56.4% vs. 30.8%, p=0.022). Surgical treatment was associated with a higher complete response rate and a lower disease progression/relapse rate (complete response rate: 87.2% vs. 53.8%, p=0.001; progression/relapse rate: 10.3% vs. 28.2%, p=0.044). Multivariate Cox regression analysis indicated that serum lactate dehydrogenase level and surgical intervention were independent prognostic factors for both PFS and OS, whereas bone marrow involvement was an independent prognostic factor for PFS.
[CONCLUSION] Combined surgical treatment manifested a better survival outcome than conservative treatment for patients with intestinal DLBCL. Serum lactate dehydrogenase level, bone marrow involvement, and surgical intervention are independent prognostic factors for survival.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Humans
- Lymphoma
- Large B-Cell
- Diffuse
- Female
- Male
- Propensity Score
- Middle Aged
- Retrospective Studies
- Survival Rate
- Prognosis
- Intestinal Neoplasms
- Aged
- Adult
- Follow-Up Studies
- Antineoplastic Combined Chemotherapy Protocols
- Conservative Treatment
- Diffuse large B-cell lymphoma
- Intestinal lymphoma
- Surgery
같은 제1저자의 인용 많은 논문 (4)
- IGSF9 promotes immunotherapy resistance in colon cancer by orchestrating an immunosuppressive tumor microenvironment and enables combinatorial targeting strategies.
- Association between low fruit consumption and elevated lung cancer mortality: epidemiological evidence from the Global Burden of Disease Study 2021.
- ASO Visual Abstract: The Role of Surgery in the Management of Intestinal Diffuse Large B-Cell Lymphoma (DLBCL): A Propensity Score-Matched Analysis.
- ASO Author Reflections: Reconsidering the Role of Surgery in Intestinal Diffuse Large B-Cell Lymphoma (DLBCL).
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.